Favrille down on FavId data

FVRL fell $1.08 (22%) to $3.88 on Monday after the company said FavId missed the secondary endpoint of response improvement versus placebo

Read the full 221 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE